View the latest Feinstein Institute for Medical Research annual report

KEVIN J. TRACEY, MDHead of the Center for Biomedical Science

As a neurosurgery resident, Dr. Tracey met an 11-month-old named Janice who arrived in an ambulance with burns covering 75 percent of her body. She was accidently burned by her grandmother who was cooking, tripped and doused Janice with a pot of boiling spaghetti. Janice spent three weeks recovering in the burn unit and eventually stabilized. At the time, Dr. Tracey played with Janice, who was happy, smiling and giggling. The next day, her medical team was shocked to find her dead. There was no medical explanation for her death, Dr. Tracey was haunted by her case and focused his career path toward researching inflammation, which he believed caused Janices unexpected death.

CENTER FOR BIOMEDICAL SCIENCE

Researchers in the Center for

Biomedical Science discovered

that the brain controls the

immune systemmore

specifically, a nerve in the neck

signals the release of natural

chemicals the body needs to treat

disease. The center is pioneering

a new field of medicine called

bioelectronic medicine, which

uses small devices to tell the

body to treat itself without

manufactured drugs or their side

eff ects. Bioelectronic medicine

has the potential to treat a wide-

ranging number of diseases,

including arthritis, lupus, obesity,

type 2 diabetes, inflammatory

bowel disease and even

certain cancers.

Dr. Tracey, center, in the lab.

9

THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

NICHOLAS CHIORAZZI, MDHead of the Center for Chronic Lymphocytic Leukemia

Dr. Chiorazzi trained at North Shore University Hospital and returned 13 years later as a scientist. It was at this time that he made discoveries in CLL B cells, which compelled Dr. Chiorazzi to turn his focus exclusively to CLL. He and his colleagues in the center have investigated the control of CLL B cell activation, and their findings have significantly impacted the understanding of leukemia cells in patients with CLL. Dr. Chiorazzi continues to conduct research in the hopes of curing the disease.

CENTER FOR CHRONIC LYMPHOCYTIC LEUKEMIA

Those in the Center for Chronic

Lymphocytic Leukemia study

the activation and maturation

of B-lymphocytes, and use this

information to develop and test

new diagnostics and treatments

for patients suff ering from chronic

lymphocytic leukemia (CLL).

CLL is a B-lymphocyte cancer

that resides in the blood, bone

marrow and lymphoid tissues.

It is the most common type of

leukemia in adults. It is called

chronic because it progresses

more slowly than other types

of leukemia.

Dr. Chiorazzi, second from left , in the lab

10

2015 ANNUAL REPORT

PETER K. GREGERSEN, MDHead of the Center for Genomics & Human Genetics

When Dr. Gregersen was a medical resident in the late 1970s, a young woman with lupus died under his care and he realized at that moment there was a need to generate knowledge about autoimmune diseases. He then began a rheumatology fellowship at a time when modern molecular biology and genetics were exploding, and he successfully cloned the first HLA genes for rheumatoid arthritis. This convinced him that research was the most important and exciting thing he could do with his life. Today, Dr. Gregersen pursues genetics research with a highly collaborative style, providing him with extraordinary connections and friendships around the world.

CENTER FOR GENOMICS & HUMAN GENETICS

The mission of the Center for

Genomics & Human Genetics

is to identify and understand

the genetic contribution to

human diseases and translate

these discoveries into new

diagnostics and therapeutics.

Center researchers are focused

on autoimmune diseases and

neuropsychiatric traits and

disorders, and conduct a full

range of human genetics research.

11


EDMUND J. MILLER, PHDHead of the Center for Heart & Lung Research

Dr. Miller started his scientific career in a pathology department, analyzing samples from patients to try to diagnose a disease state. He later joined a research group that studied acute lung injury. He was intrigued and fulfilled by this work and continues to study acute lung injury as well as chronic lung dysfunction. His current interest is in developing a better understanding of the mechanisms involved when the lung does not function properly and the consequences for both the lungs and the rest of the body. To him, the exciting part of research is the development of new ways to treat individuals with lung disease.

CENTER FOR HEART & LUNG RESEARCH

The Center for Heart & Lung

Research brings together

basic and clinical scientists

who have an interest in the

cardiopulmonary system. A major

focus of the Center is the study

of pulmonary hypertension, a

condition that can occur at any

age. Blood vessels in the lungs

narrow, causing poor blood flow

through the lungs. This results in

low oxygen in the blood, pressure

in the lungs and a strain on the

heart, which eventually causes

the heart to fail. The center

studies the cardiopulmonary

mechanisms that are

dysfunctional and their eff ects on

other organs, including the brain.

The goal of this research is to

prevent or correct the dysfunction

to improve quality of life and

prevent death.

Dr. Miller, on the left , in the lab

12

2015 ANNUAL REPORT

BARBARA SHERRY, PHDHead of the Center for Immunology & Inflammation

Growing up on Long Island, Dr. Sherry never knew a scientist, but she was always interested in science and it was her dream to work in a laboratory. In middle school, she spent a year working on her own research project that won her the schools top award and gave her the opportunity to describe her research findings to her teachers and fellow students. She loved sharing what she discovered with others. From that moment, she was determined to pursue a career in research.

CENTER FOR IMMUNOLOGY & INFLAMMATION


Immunology & Inflammation

focus on understanding the basic

biological principles of the immune

system that protects the body

against infections, environmental

hazards and internal challenges,

and how this system is impaired

in disease. They carry out basic,

translational, and patient-oriented

research on a range of immune and

inflammatory disorders, including

sepsis, allergy and hypersensitivity,

kidney injury, cancer, immune

deficiency, HIV infection and

conditions aff ecting maternal, fetal

and neonatal health. Their ultimate

goal is to develop improved

treatments and discover cures for

these life-threatening conditions.

13


YOUSEF AL-ABED, PHDHead of the Center for Molecular Innovation

Like most 14-year-olds, Dr. Al-Abed liked to play with his neighborhood friends. One day, he witnessed something that he could not comprehend; his best friend had his first seizure. No one knew what to do. For Dr. Al-Abed, those minutes were the longest of his life. Later, Dr. Al-Abed learned that his friend was diagnosed with epilepsy. He was shocked by how suddenly his friend changed from being just like him to being aff licted with illness. He was consumed with the question of how one day people can be normal and then the next day completely changed. This question compelled Dr. Al-Abed to pursue chemistry, science and medicine, inspiring his work to discover new therapies to help patients.

CENTER FOR MOLECULAR INNOVATION

The Center for Molecular

Innovation leads the discovery

and development of novel

therapeutics for human diseases,

including lupus, arthritis,

diabetes, Alzheimers disease and

sepsis. It integrates approaches

in target discovery with medicinal

chemistry to generate small

organic compounds and potential

drugs. The center has successfully

identified several drug candidates

and has repurposed existing

drugs to target critical proteins

involved in neurodegenerative

and autoimmune diseases.

Dr. Al-Abed, center, in the lab

14

2015 ANNUAL REPORT

DAVID EIDELBERG, MDHead of the Center for Neuroscience

Dr. Eidelbergs post-doctoral training led to a position in a research lab working with PET imaging. He brought PET research to North Shore University Hospital two decades ago. Since that time, he has developed novel imaging techniques that aid in diagnosing and evaluating the progression of Parkinsons disease. His state-of-the-art PET imaging methods are also used to further understand how current therapies treat Parkinsons disease.

CENTER FOR NEUROSCIENCE


Neuroscience is to shed light on

the abnormalities of functional

brain organization that underlie

nervous system disease. To

characterize these networks

as biomarkers of disease and

treatment, investigators use

multimodal brain imaging

in conjunction with novel

computational methods. Study

populations include healthy

volunteers and patients with

Parkinsons disease, Alzheimers

disease, Huntingtons disease,

dystonia and Tourette syndrome.

15


THOMAS L. ROTHSTEIN, MD, PHDHead of the Center for Oncology & Cell Biology

One Saturday morning, at age 12, Dr. Rothstein awoke with severe abdominal pain. Aft er an off ice examination, he overheard the doctor telling his parents you know, people still die from ruptured appendices. As he recovered from surgery, those words rang in Dr. Rothsteins ears. It was then that he decided to become a doctor so that he could help others. A year later, Dr. Rothstein had his first science class in 7th grade. He was, for the first time, exposed to the world of scientific thinking and was totally captivated. These two experiences put Dr. Rothstein on the track he continues to pursue today being an MD/PhD physician-scientist, who advances science to improve patients lives.

CENTER FOR ONCOLOGY & CELL BIOLOGY


Oncology & Cell Biology study

cancer and related aspects of

cell biology, all geared toward

understanding the abnormal

growth and behavior of cells

that have been malignantly

transformed. These eff orts

include finding ways to harness

the bodys own immune system

to attack cancerous growths

through antibodies and T cells,

approaches that are currently in

clinical trials.

Dr. Rothstein, center, in the lab

16

2015 ANNUAL REPORT

JEFFREY M. LIPTON, MD, PHDHead of the Center for Patient-Oriented Research

As a grade school student, aft er seeing the Soviet Union launch Sputnik in 1957, Dr. Lipton knew he wanted to be a scientist. But, his fear of heights and poor sense of direction steered him away from aerospace and toward the lab. He obtained his MD and PhD and his long-standing interest in the biology of blood cell production led him to focus on Diamond-Blackfan anemia.

CENTER FOR PATIENT-ORIENTED RESEARCH

The major goal for investigators

in the Center for Patient-Oriented

Research is patient-directed

research. This includes clinical

trials, epidemiology and

statistics and focused laboratory

science. For example, a team of

researchers in the center focuses

on the elucidation of the genetics

and pathophysiology of Diamond-

Blackfan anemia (DBA), a rare

bone marrow disorder. They work

to translate laboratory knowledge

into relevant diagnostic and

therapeutic tools.

Dr. Lipton, on the right, in the lab

17


JOHN M. KANE, MDHead of the Center for Psychiatric Neuroscience

Dr. Kane has been fascinated by behavior and emotion since he was a child. In medical school, he encountered a patient who suff ered from schizophrenia and bizarre delusions. Dr. Kane was intrigued by these dramatic and disabling symptoms, and was even more interested in how medicines available at the time reduced patients symptoms. Since that day, Dr. Kane has been dedicated to researching drug discovery and the development of new treatments for schizophrenia.

CENTER FOR PSYCHIATRIC NEUROSCIENCE


Psychiatric Neuroscience is to

study behavioral health to identify

causes, triggers, markers and

treatments for such illnesses as

bipolar disorder, schizophrenia

and other psychotic disorders.

Combining diff erent perspectives

in multi-disciplinary research is

key to making advances in these

illnesses. The Feinstein Institute

and the Zucker Hillside Hospital

provide valuable platforms to

advance such eff orts.

18

2015 ANNUAL REPORT

PING WANG, MDHead of the Center for Translational Research

Dr. Wang grew up in an industrial city where there was much emphasis on machinery. Being born and raised in this environment, it was natural for him to have a deep interest in figuring out how and why machines worked the way they did. When medicine was introduced to him later in life, he applied his interest in machinery and grew a curiosity to discover how the human body works and what causes disease. Today, Dr. Wang believes that parts of the human body work together to form a beautiful machine that is far more complicated than anything humans have created or even imagined. He works toward the goal of conducting eff ective and successful laboratory discoveries and translating them into clinical practice for improving patient outcome.

THE CENTER FOR TRANSLATIONAL RESEARCH

The Center for Translational

Research promotes the

identification of therapeutic

targets, the development

of treatment strategies,

and the validation of

preclinical studies, leading to

commercialized technologies

for diagnosing or treating

human disease. Through

cohesive collaboration,

researchers in the center work

together and share ideas in

hope of advancing biomedical

technologies in various

research fields.

19


There are 800 Feinstein Institute investigators and staff who conduct research in immunology, inflammation, neurology, obstetrics/gynecology, oncology, pediatrics, psychiatry, surgery, urology, genetics and many other specialties. These scientists collaborate with nearly 10,000 physicians across the North Shore-LIJ Health System. Together, they touch the lives of millions of patients each year in the health systems 19 hospitals, more than 400 outpatient physician practices and a vast network of skilled-nursing home care rehabilitation facilities. The health systems 2,200-square-mile footprint throughout the New York metropolitan area includes some of the most ethnically-diverse communities in the US, providing an immense opportunity for clinical research faculty and staff who recruit more than 15,000 subjects per year into more than 2,100 studies.

Feinstein Institute investigators are internationally-acclaimed authorities in their scientific and medical fields. They win prestigious awards, belong to exclusive scientific and medical honor societies, and are invited worldwide to lecture about their research. Their discoveries are published in the most prestigious scientific and medical journals.

The directory to follow highlights select Feinstein Institute investigators organized first by their specialty and then alphabetically by name.

* this directory includes researchers who have a Feinstein Institute appointment, are Investigators and/or are on a scientific track.

RESEARCH DIRECTORY

20

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Autoimmune Research

AUTOIMMUNE & MUSCULOSKELETAL DISEASECynthia Aranow, MD Ona E. Bloom, PhDNadeen Chahine, PhD Anne Davidson, MBBSBetty Diamond, MDGiovanni Franchin, MD, PhD Richard A. Furie, MDPatricio Huerta, PhD Sun Jung Kim, PhDCzeslawa Kowal, PhDMeggan Mackay, MD Frances Santiago-Schwarz, PhDMyoungsun Son, PhDAndrea Vambutas, MDYong-Rui Zou, PhD

BIOMEDICAL SCIENCESangeeta S. Chavan, PhDCliff Deuschman, MDJared Huston, MD Valentin A. Pavlov, PhDJesse Roth, MDKevin J. Tracey, MDBruce T. Volpe, MD Haichao Wang, PhD Huan Yang, MD, PhD

IMMUNOLOGY & INFLAMMATIONVincent R. Bonagura, MDSleiman Ghorayeb, PhDChristine Metz, PhDRichard J. Schanler, MDBarbara Sherry, PhDPravin C. Singhal, MD

Brain Research

ALZHEIMERS DISEASE & MEMORY DISORDERSPeter Davies, PhDConcepcion Goldberg, MD, PhDMarc L. Gordon, MDPhilippe Marambaud, PhD

NEUROSCIENCEJohn Boockvar, MDStephen L. Dewey, PhDVijay Dhawan, PhDDavid Eidelberg, MD Deborah Elkis-Abuhoff, PhDAndrew S. Feigin, MDChunyan Li, PhDAshesh Mehta, MD, PhD Michael Schulder, MDAziz M. Ulug, PhD

PSYCHIATRIC NEUROSCIENCEBarbara A. Cornblatt, PhDChristoph U. Correll, MD Juan A. Gallego, MDTerry Goldberg, PhD Vivian Kafantaris, MDJohn M. Kane, MDKatherine Karlsgodt, PhDJeremy Koppel, MDTodd Lencz, PhDAnil Malhotra, MDDelbert G. Robinson, MD Keith M. Shafritz, PhDPhilip R. Szeszko, PhDJianping Zhang, MD, PhD

Cancer Research

CHRONIC LYMPHOCYTIC LEUKEMIA Nicholas Chiorazzi, MD Charles C. Chu, PhD Patricia K.A. Mongini, PhD Kanti R. Rai, MD

ONCOLOGY & CELL BIOLOGYLionel Blanc, PHD Daniel R. Budman, MDDaniel A. Grande, PhDBenchang Guo, PhDJohnson Liu, MDLouis Potters, MD Thomas L. Rothstein, MD, PhDRosamaria Ruggieri, PhDSharon Singh, MDSamuel Z. Soffer, MDBettie M. Steinberg, PhDMarc H. Symons, PhDSarah Vaiselbuh, MD

Genomics & Human GeneticsPeter K. Gregersen, MDAnnette T. Lee, PhD

Heart & Lung ResearchHarly Greenberg, MD Shu Fang Liu, MD, PhD Edmund Miller, PhD Kaie Ojamaa, PhD Saul R. Powell, PhD Arunabh Talwar, MD

Molecular InnovationYousef Al-Abed, PhD

Patient-Oriented ResearchLouis R. Kavoussi, MDMartin L. Lesser, PhDJeffrey M. Lipton, MD, PhDThomas McGinn, MDJacqueline Moline, MD Raj K. Narayan, MDRenee Pekmezaris, PhDCharles Schleien, MD Robert A. Silverman, MDHenry Simpkins, MD, PhDAdrianna Vlachos, MD

Translational ResearchMax Brenner, MD, PhDHoracio Rilo, MDPing Wang, MD

21


RESEARCH DIRECTORY

Dr. Al-Abed leads the Center of Molecular Innovation, which aims to discover and develop novel therapeutics for human diseases including lupus, arthritis, diabetes, Alzheimers disease and sepsis. This research integrates target discovery with medicinal chemistry to generate small organic compounds and potential drugs.

Recurrent respiratory papillomatosis (RRP) is a disease caused by the human papillomavirus (HPV)it is the recurrence of tumors of the upper airway that can lead to airway blockages and suffocation. Dr. Bonagura studies the immune response to HPV to understand why RRP patients do not produce the needed immune response to prevent or control the virus.

Dr. Aranow specializes in lupus and rheumatoid arthritis. She is the clinical director of the Feinstein Institute Center for Clinical Research in Autoimmune Disease and co-director of the Clinical Trials Unit. She conducts studies to better understand and develop treatments for diseases such as lupus and rheumatoid arthritis.

Dr. Boockvars research interests focus on malignant brain tumor formation, treatment and ways to overcome resistance to therapy. In addition to his basic science interests, he currently conducts multiple clinical trials using blood-brain barrier disruption to deliver high-dose chemotherapy for patients with malignant brain tumors.

Dr. Blancs research focuses on developmental erythropoiesis and its impairment in pathological conditions and why genetic disorders in erythroid development trigger a cancer predisposition in children, notably osteogenic sarcoma.

Dr. Brenners research goal is to discover and develop better treatments for patients with autoimmune and inflammatory diseases. Recent areas of focus include rheumatoid arthritis and inflammatory bowel disease.

The focus of Dr. Blooms research is to identify the molecular factors necessary to recover from central nervous system (CNS) injury or disease. Towards that goal, her lab is investigating factors that influence the course of CNS injury or disease, as well as the process to recover from CNS injury or disease.

Dr. Budman conducts preclinical, translational and phase I, II and III clinical research in an effort to determine new drug developments for cancer.

YOUSEF AL-ABED, PHDMolecular Innovation

VINCENT R. BONAGURA, MDImmunology & Inflammation

CYNTHIA ARANOW, MD Autoimmune &

Musculoskeletal Disease

JOHN BOOCKVAR, MDNeuroscience

LIONEL BLANC, PHDOncology & Cell Biology

MAX BRENNER, MD, PHDTranslational Research

ONA E. BLOOM, PHDAutoimmune &


DANIEL R. BUDMAN, MDOncology & Cell Biology

22

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Chahines research focuses on degeneration and regeneration of musculoskeletal tissues, particularly intervertebral disc, articular cartilage and tendonous tissues. Her lab uses tools of bioengineering, cellular and molecular biology and animal physiology to develop new treatment strategies for repairing arthritic and diseased musculoskeletal tissues.

The major focus of Dr. Chavans research is in bioelectronic medicine, and developing knowledge about the neuroanatomical pathways and neural codes in the vagus nerve that underlie its regulation of the immune response. She also works to develop targeted therapeutics for the treatment of long-term effects of inflammatory diseases.

Dr. Cornblatts research focus is on the early identification and treatment of adolescents and young adults who are considered to be at-risk for developing serious psychiatric illness as adults, especially schizophrenia and other psychotic disorders. She directs the Recognition and Prevention (RAP) program.

Dr. Chiorazzi studies the activation and maturation of B-lymphocytes, and uses this information to develop and test new diagnostics and treatments for patients suffering from chronic lymphocytic leukemia (CLL), a B-lymphocyte cancer residing in the blood, bone marrow and lymphoid tissues. His studies have impacted CLL patient prognosis and care.

Dr. Correll researches the identification and treatment of patients with severe psychiatric disorders. His areas of focus include schizophrenia-spectrum, mood-spectrum and aggressive-spectrum disorders. He is also an expert in the risk-benefit evaluation of psychotropic medications.

Dr. Chus research interests are currently focused on understanding the molecular basis for the development of B cell chronic lymphocytic leukemia (CLL). More broadly, he is interested in B cell biology, particularly B cell maturation and development and its relationship to disease and autoimmunity.

The current interests of Dr. Davidson are focused on pathogenesis and therapy of lupus. Her labs first goal is to understand more about the regulation of autoantibody-producing B cells and to use newly-discovered pathways of immune activation to design and test novel therapies for lupus.

NADEEN CHAHINE, PHD Autoimmune &


SANGEETA S. CHAVAN, PHD Biomedical Science

BARBARA A. CORNBLATT, PHDPsychiatric Neuroscience

NICHOLAS CHIORAZZI, MDChronic Lymphocytic Leukemia

CHRISTOPH U. CORRELL, MDPsychiatric Neuroscience

CHARLES C. CHU, PHDChronic Lymphocytic Leukemia

ANNE DAVIDSON, MBBSAutoimmune &


The major goal of Dr. Davies research is to improve the understanding of Alzheimers disease to allow for the discovery, development and testing of effective therapies. Recent work focuses on activation of cell cycle mechanisms in Alzheimers disease and modifications of the microtubule associated protein tau as a reporter for signal transduction in the human brain.

PETER DAVIES, PHDAlzheimers Disease &

Memory Disorders

23


RESEARCH DIRECTORY

Dr. Feigin directs the Laboratory of Experimental Therapeutics for Movement Disorders, which conducts clinical trials of new therapies for Parkinsons disease, Huntingtons disease and other movement disorders. Dr. Feigin is particularly interested in utilizing PET imaging methods as a biomarker for neurodegenerative disorders in the preclinical phase of illness.

Dr. Dhawans research focuses on how biophysics and bioengineering can be applied to neuroscience, and particularly to the study of disease mechanisms in movement disorders and other neurodegenerative conditions.

Dr. Franchins recent focus is on clinical research and patient care. He is interested in lupus and rheumatoid arthritis, and is involved with clinical trials looking at new therapeutic targets for these diseases. He is also investigating the link between metabolism and disease activity in patients with lupus.

Dr. Diamond studies the induction and pathogenicity of DNA-reactive antibodies in lupus. These studies are designed to provide new strategies to prevent autoimmunity or protect against tissue damage in lupus. She also studies the contribution of maternal antibody to abnormal brain development.

Dr. Deutschman investigates sepsis. Laboratory work includes determinants of organ dysfunction, with emphasis on mitochondrial dysfunction, aberrant signal transduction and abnormalities of neural and endocrine control mechanisms. Clinical projects focus on epidemiologically based definitions of sepsis. He is also involved in both laboratory and clinical investigations throughout the Department of Pediatrics.

Dr. Eidelberg directs an imaging research program in brain disease. His program has developed novel imaging techniques to characterize and quantify neural circuits in neurodegenerative disorders and to study their modulation by using functional imaging with PET and fMRI. This approach has provided unique insights into Parkinsons disease and related movement disorders.

Dr. Dewey studies the effects of substance abuse on brain function and structure. He has researched brain exposure to caffeine, tobacco, alcohol, marijuana, cocaine, methamphetamine, opiates, heroin and chemical solvents, and most recently focused on developing a novel treatment for drug abuse.

Dr. Elkis-Abuhoffs research interests bring together behavioral medicine and creative/medical art therapy with neuroscience. Her recent research projects connect art therapy with those diagnosed with Parkinsons disease, cancer and connecting the creative process to neurological responses.

ANDREW S. FEIGIN, MD Neuroscience

VIJAY DHAWAN, PHDNeuroscience

GIOVANNI FRANCHIN, MD, PHD Autoimmune &


BETTY DIAMOND, MDAutoimmune &


CLIFF DEUTSCHMAN, MDBiomedical Science

DAVID EIDELBERG, MDNeuroscience

STEPHEN L. DEWEY, PHDNeuroscience

DEBORAH ELKIS-ABUHOFF, PHDNeuroscience

24

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Ghorayebs research includes diagnostic and therapeutic ultrasound in orthopaedics, dentistry, ophthalmology, urology and obstetrics and gynecology. Projects include assessment of osteoporosis; dental pulp stem cells; penile, testicular and cervical tissue characterization; retinal reattachment; and evaluation of cartilage implanted with preconditioned scaffolds.

Dr. Goldberg works to examine RNAs found in the brain using microarray technology. She studies abnormal expression of RNA in tissue from people at high risk or currently suffering from Alzheimers disease. She is working to identify novel brain chemicals that can become treatment targets for new drugs.

The goal of Dr. Furies research is to investigate the signaling pathways in myeloproliferative diseasesa group of conditions that cause blood cells to grow abnormally in the bone marrowover the course of the disease. Understanding these mechanisms could allow for the development of more efficacious and better-targeted therapies.

Dr. Goldberg is designing the next generation of neurocognitive assessments for patients with psychiatric disease. These tests will be used to diagnose and follow patients over time to see whether the treatments help in improving symptoms.

Dr. Gallegos current research focus is on the role of microRNAs in cerebrospinal fluid and peripheral blood in patients with schizophrenia. Additionally, he is conducting a study using induced pluripotent stem cells derived from first-episode psychosis patients.

The focus of Dr. Gordons research is in behavioral neurology and neuropsychiatry. He leads clinical research studies in Alzheimers disease, mild cognitive impairment and vascular dementia. His current research involves clinical trials of novel medications, biomarker studies and imaging techniques.

SLEIMAN GHORAYEB, PHDImmunology & Inflammation

CONCEPCION GOLDBERG, MD, PHDAlzheimers Disease &

Memory Disorders

RICHARD A. FURIE, MDAutoimmune &


TERRY GOLDBERG, PHD Psychiatric Neuroscience

JUAN A. GALLEGO, MDPsychiatric Neuroscience

MARC L. GORDON, MDAlzheimers Disease &

Memory Disorders

Dr. Grandes research aims to improve treatments for injuries of the musculoskeletal system, including cartilage regeneration and repair, meniscus repair, tendon repair and bone fracture augmentation and fusion. Recent focus has been on developing novel cell-modified scaffolds for enhancing tendon repair and methods to provide gene therapy and tissue-engineered constructs for bone injuries.

Dr. Greenbergs educational and research efforts are in the field of sleep medicine. Recent work has focused on the cardiovascular pathophysiology of sleep apnea and intermittent hypoxia, assessing functional outcomes of sleep apnea therapy and on developing novel diagnostic and screening modalities for sleep-disordered breathing.

DANIEL A. GRANDE, PHDOncology & Cell Biology

HARLY GREENBERG, MD Heart & Lung Research

25


RESEARCH DIRECTORY

Dr. Karlsgodts research investigates the neural circuitry underlying the executive functions, such as working memory, in individuals with severe psychiatric illness. Her work has incorporated methods such as functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI) and studies in relevant patient populations such as schizophrenia and bipolar disorder.

Dr. Huerta is interested in exploring the interactions between the nervous system and the immune system in health and disease. He currently studies brain abnormalities occurring in lupus and sepsis-induced long-term cognitive deficit, with the goal to isolate key immune and neural mechanisms with the purpose of creating therapies for autoimmunity and brain disorders.

Dr. Kavoussi is dedicated to the treatment of urological disease through innovative surgical procedures, diagnostics and medical care.

The focus of Dr. Hustons research is to understand how the central nervous system maintains homeostasis and protects against traumatic injury. He is currently studying the beneficial effects of vagus nerve stimulation with the hope that it can improve care of traumatized patients.

Dr. Gregersen conducts international collaboration efforts to achieve a comprehensive genetic description for autoimmune diseases, with a particular focus on lupus and rheumatoid arthritis. He also studies a number of newly defined risk genes for autoimmunity, several of which are potential targets of new drugs.

Dr. Kafantaris main research focus is the pharmacological treatment of bipolar disorder and the related area of severe dysregulated aggression associated with conduct disorder or oppositional defiant disorder. She currently studies the neurodevelopmental underpinnings of bipolar disorder and treatment with lithium.

Dr. Guo studies antigen-initiated B cell activation under the influence of T cells. He works to find a dialogue between B cells and T cells in immunity.

Dr. Kanes focus is in the field of schizophrenia research. His work has focused on improving the early diagnosis and treatment of schizophrenia, as well as developing new treatments and treatment strategies to enhance patient long-term effectiveness and quality of life.

KATHERINE KARLSGODT, PHD Psychiatric Neuroscience

PATRICIO HUERTA, PHD Autoimmune &


LOUIS R. KAVOUSSI, MD Patient-Oriented Research

JARED HUSTON, MDBiomedical Science

PETER K. GREGERSEN, MDGenomics & Human Genetics

VIVIAN KAFANTARIS, MDPsychiatric Neuroscience

BENCHANG GUO, PHDOncology & Cell Biology

JOHN M. KANE, MDPsychiatric Neuroscience

26

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Kowals research focuses on the mechanisms of the antibody-mediated neuronal abnormalities leading to brain pathology and to hormonal serum alterations in lupus. Projects include the function of the blood-brain barrier in the antibody-mediated pathology of the adult brain and of the maternal antibody-mediated abnormalities in the developing brain.

Dr. Lees current research focus is to discover and validate new biomarkers for early detection, prediction of disease course and outcome and treatment response in cancer, particularly breast and ovarian cancers.

The focus of Dr. Kims research is to identify regulatory mechanisms of inflammatory function of dendritic cells under both homeostatic and inflammatory conditions. This is with the goal to understand the molecular mechanisms that inhibit the development of autoimmune diseases, particularly in lupus and inflammatory bowel diseases.

Dr. Lencz researches the use of biomarkers, especially novel genetic technologies, to better understand the causes and treatment of schizophrenia. He develops and implements strategies for identifying relationships between genetic variation and psychiatric disease, and examines the role that schizophrenia risk genes play in brain structure, function and development.

Dr. Koppels research program focuses on elucidating the biology of behavioral disturbances in Alzheimers disease and the development of novel treatments. Recent work has focused on the endocannabinoid system in Alzheimers disease and the contribution of abnormal tau protein deposition to the development of psychotic symptoms.

Dr. Lesser is a biostatistician and assists investigators in data analysis, research question formulation, study design, data management, storage and retrieval, as well as publication preparation and patient safety and data quality monitoring.

CZESLAWA KOWAL, PHDAutoimmune &


ANNETTE T. LEE, PHDGenomics & Human Genetics

SUN JUNG KIM, PHDAutoimmune &


TODD LENCZ, PHDPsychiatric Neuroscience

JEREMY KOPPEL, MDPsychiatric Neuroscience

MARTIN L. LESSER, PHDPatient-Oriented Research

Dr. Lis research is focused on monitoring and treating the injured brain. Projects include developing the next generation brain multimodality monitoring devices using BioMEMS technology, and investigating trigeminal nerve stimulation as a novel therapeutic approach to traumatic brain injury by the activation of endogenous neuroprotective mechanisms.

The goal of Dr. Liptons research is the elucidation of the genetics and pathophysiology of Diamond-Blackfan anemia (DBA), a disorder of the bone marrow. He is working with numerous collaborators to develop genotype-phenotype correlations, resulting in the discovery of a number of DBA genotypes.

CHUNYAN LI, PHDNeuroscience

JEFFREY M. LIPTON, MD, PHD Patient-Oriented Research

27


RESEARCH DIRECTORY

Dr. McGinn has taught, researched and worked in the area of academic general internal medicine with a focus on providing high-quality health care in urban communities. Recent areas of focus include the validation of clinical prediction rules, as well as the prevalence, risk factors and treatment of hepatitis C.

Dr. Mehtas lab uses multiple methods for measuring brain structure and function to advance understanding of human brain function and the treatment of epilepsy. The lab works to improve the diagnosis of epilepsy patients, and better understand the root causes of epilepsy, and the physiological basis of brain structure, function and cognition.

Dr. Mackay is a rheumatologist whose primary interests are in lupus, rheumatoid arthritis, scleroderma and vasculitis. She is a co-director of the Clinical Trials Unit and conducts studies to better understand and develop treatments for autoimmune disease.

Dr. Lius research career has focused on the molecular basis of hematopoietic stem cell disorders, collectively referred to as the inherited bone marrow failure syndromes. His current research is aimed at understanding the molecular pathophysiology of Diamond Blackfan anemia and Shwachman-Diamond syndrome. His lab also researches erythropoiesis and sickle cell anemia.

Dr. Metzs research focuses on inflammation in both pregnant and non-pregnant populations and identifying ways to reduce and prevent dysfunctional inflammation. Much of her work centers on endothelial cells, which facilitate the rapid transport of blood and immune cells throughout the body, particularly to sites of infection and inflammation.

Dr. Malhotra works on identifying the biological underpinnings of schizophrenia and determining how antipsychotic drugs work to quell the symptoms of the disease. His group assesses genes and neural circuits associated with increased risk for schizophrenia with the goal of developing more effective treatments.

Dr. Lius research focus is on molecular mechanisms of septic shock, and septic multiple organ injury. Using modern molecular biology techniques, his goal is to discover the key molecules that can be new targets for developing new therapies.

Dr. Marambauds research focuses on the molecular basis of neuronal degeneration in Alzheimers disease and other dementias. His laboratory studies the early biochemical changes leading to the formation of two classic lesions of the Alzheimers disease brain: the senile plaques and the neurofibrillary tangles.

THOMAS MCGINN, MD Patient-Oriented Research

ASHESH MEHTA, MD, PHD Neuroscience

MEGGAN MACKAY, MD Autoimmune &


JOHNSON LIU, MDOncology & Cell Biology

CHRISTINE METZ, PHDImmunology & Inflammation

ANIL MALHOTRA, MDPsychiatric Neuroscience

SHU FANG LIU, MD, PHDHeart & Lung Research

PHILIPPE MARAMBAUD, PHDAlzheimers Disease &

Memory Disorders

28

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Moline develops initiatives aimed at promoting and engaging health and wellness, and she oversees a population health and epidemiology research program. Her research interests include World Trade Center health effects, asbestos exposure, occupational lung disorders and heavy metal toxicity.

Dr. Monginis research focuses on the immune systems B cells and why B cells sometimes become pathogenic and cause disease. Understanding how to prevent the abnormal development of pathogenic B cells is a critical challenge particularly given the greater emergence of B cell malignancy and certain autoimmune diseases with increased age.

Dr. Narayans research aims to develop the next generation of human monitoring devices, with a particular focus on the monitoring of the injured brain. His recent work has focused on the development of a smart catheter for the monitoring of multiple physiological parameters simultaneously with a single monitor.

Dr. Millers research focuses on lung inflammation and the role of the lung as an inflammatory organ. The studies in his lab involve both acute and chronic disorders that impact the lung. He is closely studying the role of MIF in severe sepsis and pulmonary hypertension.

The goal of Dr. Ojamaas research is to understand the causes of heart disease so that novel therapeutics can be developed. She studies inflammation and neuro-hormones during a heart attack, and why the heart often fails in the long term. In the newborn patient with congenital heart defects, her studies address how increased inflammation may affect neurodevelopment.

JACQUELINE MOLINE, MD Patient-Oriented Research

PATRICIA K.A. MONGINI, PHDChronic Lymphocytic Leukemia

RAJ K. NARAYAN, MDPatient-Oriented Research

EDMUND MILLER, PHD Heart & Lung Research

KAIE OJAMAA, PHD Heart & Lung Research

Dr. Pavlovs research focuses on the regulation of immune function and inflammation by the nervous system. He studies the role of brain and peripheral neuronal pathways in controlling cytokine responses and inflammation, and the therapeutic efficacy of cholinergic modalities in inflammatory and obesity-driven disorders and cancer-associated immune dysfunction.

With an emphasis on the growing population of seniors, Dr. Pekmezaris conducts community-based research investigations with seniors, including telehealth trials for patients living with congestive heart failure, a randomized trial in anemia of chronic disease and a study to predict site of death in end of life patients.

Dr. Potters conducts research in prostate cancer, with a focus on prostate brachytherapy techniques and outcomes. He also works on systems and process research for high-quality and safe treatment of innovative care and delivery models.

VALENTIN A. PAVLOV, PHDBiomedical Science

RENEE PEKMEZARIS, PHD Patient-Oriented Research

LOUIS POTTERS, MD Oncology & Cell Biology

29


RESEARCH DIRECTORY

Dr. Rothsteins lab aims to clarify the role and function of B lymphocytes in health and disease. His focus is on human B1 cells, a unique B lymphocyte subset that produces natural antibody and regulates T-cell activity. Human B1 cells may be important in understanding and treating autoimmune diseases and degenerative diseases of aging.

Dr. Rai collaborates in basic and clinical research to conduct a number of experimental drug trials for patients suffering from chronic lymphocytic leukemia (CLL), a cancer that resides in the blood, bone marrow and lymphoid tissues. His studies have impacted CLL patient prognosis and care.

Dr. Ruggieri researches glioblastoma and medulloblastoma, the most common types of brain tumors in adults and children. She is working on the development of an inhibitor that could provide novel treatments for these types of tumors.

Dr. Rilos expertise are conducting clinical islet cell transplant for patients suffering from chronic pancreatitis and type 1 diabetes, and performing immunotherapy for pancreatic cancer. His research focuses on mitigating transplant rejection, preservation of donor organs and development of stem cell therapies to treat life-threatening diseases.

Dr. Santiago-Schwarzs research is concerned with the control of monocyte and dendritic cell development in normal and abnormal physiology as well as developing new therapeutic agents for autoimmune diseases. Current work focuses on disrupted cytokine and immunoreceptor networks affecting monocyte/dendritic cell activity, particularly in rheumatoid arthritis and lupus.

Dr. Robinson and his first-episode schizophrenia research network, which includes sites across the country and in Canada, study pharmacotherapy for schizophrenia. The network is currently conducting the RAISE trial, which assesses psychosocial and pharmacological treatments for schizophrenia.

Dr. Powell is involved in cardiac metabolism research and examines the role of the ubiquitin proteasome system in cellular function and malfunction. He conducts ongoing studies that examine altered function of the ubiquitin proteasome system in several diseases.

Dr. Roths research is focused on obesity and diabetes. Projects include devising earlier ways to diagnose and treat diabetes, understanding how excess body weight brings out diabetes, and uncovering how the microbiome, the microbes in the intestine of the host, influence the hosts food intake and body weight.

THOMAS L. ROTHSTEIN, MD, PHD Oncology & Cell Biology

KANTI R. RAI, MD Chronic Lymphocytic Leukemia

ROSAMARIA RUGGIERI, PHD Oncology & Cell Biology

HORACIO RILO, MD Translational Research

FRANCES SANTIAGO-SCHWARZ, PHDAutoimmune &


DELBERT G. ROBINSON, MDPsychiatric Neuroscience

SAUL R. POWELL, PHD Heart & Lung Research

JESSE ROTH, MDBiomedical Science

30

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Schleien researches cardiopulmonary resuscitation, including brain-blood flow, drug effects, metabolism and mechanics of CPR. Recently, his focus has been in pediatric CPR and hypothermia following cardiac arrest in children. He also has an interest in clinical bioethics in children, as well as other critical care topics.

Dr. Schulder investigates new methods of image guidance for neurosurgery, including the incorporation of functional MRI as well as intraoperative MRI.

Dr. Shafritzs research examines the neural and cognitive mechanisms of attention, executive function and emotion. He also studies psychological disorders that involve dysregulation of these processes, such as autism and attention deficit hyperactivity disorder. He works to determine the brain mechanisms underlying behavioral disorders so that future treatments can target those specific brain areas.

Dr. Schanler researches neonatal nutrition and critical inflammatory disorders of newborns. His nutritional and anti-inflammatory studies aim to provide better outcomes for infants in the neonatal intensive care unit.

Dr. Sherrys research interest is in the mechanisms that coordinate the innate immune response. Her ultimate goal is to gain a better understanding of the molecular mechanisms that regulate chemokine and chemokine receptor responses in healthy individuals, and to identify how these pathways are dysregulated in sepsis, HIV infection and chronic lymphocytic leukemia.

CHARLES SCHLEIEN, MD Patient-Oriented Research

MICHAEL SCHULDER, MDNeuroscience

KEITH M. SHAFRITZ, PHDPsychiatric Neuroscience

RICHARD J. SCHANLER, MD Immunology & Inflammation

BARBARA SHERRY, PHD Immunology & Inflammation

Dr. Silverman researches pre-diabetes and diabetes in emergency room patients, as well as the effects of air pollution on asthma-related hospital admissions. He also studies air pollution and cardiac deaths that occur outside of the hospital.

Dr. Simpkins uses si/sh RNA knockdown techniques to study the molecular mechanisms of cisplatin resistance that develops in tumor cells. He is studying his area of medicine to create safer, more effective chemotherapies.

Dr. Singh is focused on elucidating the pathways responsible for the cancer predisposition in patients with bone marrow failure syndromes. A recent research focus is on determining the impact of ribosomal protein haploin sufficiency on the immune system.

ROBERT A. SILVERMAN, MDPatient-Oriented Research

HENRY SIMPKINS, MD, PHDPatient-Oriented Research

SHARON SINGH, MD Oncology & Cell Biology

31


RESEARCH DIRECTORY

Dr. Symons has focused his research on the molecular dissection of signaling pathways that are responsible for tumor cell invasion and survival, with current emphasis on brain tumors. The research focuses on two types of malignant tumors: glioblastoma and medulloblastoma.

Dr. Soffer studies mechanisms of metastasis and resistance to anti-angiogenic therapies in pediatric soft tissue sarcomas. The goal is to prevent micro-metastatic disease following tumor resection in a host of pediatric solid tumors.

Dr. Szeszko uses MRI to study the brains of patients who suffer from psychiatric disorders in order to identify structural and functional abnormalities that play a role in the pathogenesis of disorders including schizophrenia, bipolar disorder and obsessive-compulsive disorder. He also identifies neuroimaging predictors of treatment response and outcome.

The research focus of Dr. Son is on a pathogenic pathway in lupus; specifically the fundamental tolerance role of complement C1q in immune system. She studies the function of LAIR-1 and manipulating C1q and LAIR-1 for down-regulation of myeloid cells to improve the severity of lupus.

Dr. Talwar studies translational research in pulmonary medicine with a focus on pulmonary hypertension and advanced lung disease. He also researches comorbidities of these diseases and their impact on patients mental health and quality of life.

Dr. Singhals research is focused on studying the mechanism of the progression of renal lesions in patients with HIV-associated nephropathy (HIVAN), a complication of AIDS. He also studies the effects of opiates and ethanol on T cell injury.

Dr. Traceys research focus is inflammation, the physiological and immunological response to infection and injury and the mechanism by which neurons control the immune system. Most recently, he has made discoveries in bioelectronic medicine. Bioelectronic medicine tells nerves to produce the natural chemicals the body uses to cure itself.

Dr. Steinbergs research is primarily focused on diseases of the airway caused by human papillomaviruses (HPVs). One of these diseases is recurrent respiratory papillomatosis (RRP). She also studies HPV-induced head and neck cancers.

MARC H. SYMONS, PHD Oncology & Cell Biology

SAMUEL Z. SOFFER, MD Oncology & Cell Biology

PHILIP R. SZESZKO, PHD Psychiatric Neuroscience

MYOUNGSUN SON, PHD Autoimmune &


ARUNABH TALWAR, MDHeart & Lung Research

PRAVIN C. SINGHAL, MD Immunology & Inflammation

KEVIN J. TRACEY, MD Biomedical Science

BETTIE M. STEINBERG, PHDOncology & Cell Biology

32

2015 ANNUAL REPORT

RESEARCH DIRECTORY

Dr. Ulug is experienced in functional applications of MRI, such as functional MRI (fMRI) and MR spectroscopic imaging (MRSI). His research focuses on neuroimaging applications of MR diffusion tensor imaging (DTI).

Dr. Vaiselbuh specializes in histiocytic disorders, pediatric leukemia and lymphoma and her research focuses on stem cell niche biology and the tumor microenvironment.

Dr. Vambutass research interests are in the restoration of natural hearing in patients with immune-mediated hearing loss who are resistant to conventional corticosteroid therapy. She is currently studying how to prevent further hearing loss and identify new biologic markers in these patients.

Dr. Vlachoss research focuses on inherited bone marrow failure syndromes, particularly Diamond Blackfan anemia (DBA). Her goal is to better understand the epidemiology and biology of this red cell disorder, and ultimately discover better diagnostic and treatment options.

AZIZ M. ULUG, PHD Neuroscience

SARAH VAISELBUH, MDOncology & Cell Biology

ANDREA VAMBUTAS, MDAutoimmune &


ADRIANNA VLACHOS, MD Patient-Oriented Research

Dr. Volpe studies recovery after neurological injury with non-invasive technology including interactive robot training and transcranial direct current stimulation (tDCS). His group is also exploring the effect of repetitive trans-cranial magnetic stimulation (rTMS) on brain metabolism using PET technology.

The intent of Dr. Wangs research is to uncover the mechanisms underlying the pathogenesis of inflammatory diseases, including cerebral ischemic injury and sepsis. He is working to identify novel therapeutic targets to fight against severe injury- and infection-elicited dysregulated inflammation.

Dr. Wangs research goal is to develop better therapies to prevent septic onset and progression. He and his team members are studying several potential drug candidates for the treatment of sepsis and other organ injuries including hemorrhagic shock, acute kidney injury, ischemia-reperfusion injury, stroke and radiation injury.

Dr. Yang studies the immune system and diseases caused by inflammation, with a focus on sepsis. Specifically, she studies the molecular basis of sepsis in order to develop an improved treatment for sepsis.

BRUCE T. VOLPE, MDBiomedical Science

HAICHAO WANG, PHD Biomedical Science

PING WANG, MD Translational Research

HUAN YANG, MD, PHD Biomedical Science

33


RESEARCH DIRECTORY

Dr. Zhangs research goal is to improve treatment outcomes of patients with schizophrenia and other psychiatric disorders. Current research is focused on pharmacogenomics of antipsychotic drug response, using genomic markers to predict medication efficacy and side effects. He treats and studies patients with early stages of schizophrenia.

Dr. Zou studies hematopoietic stem cell (HSC) function under normal and inflammatory conditions. Another current focus is on how inflammatory factors affect the bone morrow microenvironment and differentiation of stromal cells in lymphoid organs in autoimmune diseases.

JIANPING ZHANG, MD, PHD Psychiatric Neuroscience

YONG-RUI ZOU, PHD Autoimmune &


34

2015 ANNUAL REPORT

Robert B. CatellAnthony Cerami, PhDNicholas Chiorazzi, MDSusan B. ClasterSteven M. CohenThomas J. Degnan, MDMichael A. EpsteinLeonard FeinsteinLloyd M. GoldmanSusan KarchesCurt N. LaunerMarjorie Boas Levins

Seth LipsayNancy A. MarksCharles MerinoffSusan L. MerinoffEdward D. MillerRalph A. NappiPeter J. Pappas, JrLewis S. RanieriJack J. RossMichael C. SladeKevin J. Tracey, MDBarbara Hrbek Zucker

Mark L. ClasterMichael J. DowlingLaurence A. KraemerLaura S. Peabody

Robert S. ShapiroBettie M. Steinberg, PhDAndrew C. Yacht, MD

BOARD OF DIRECTORS

EX-OFFICIOS

35


Philanthropy and Health System Support

$45,583,188

Grants Revenue$44,445,382

Licensing, Royalties and Other

$2,342,043

Total Research Investment

$73,848,962

Facilities and Capital Spending

$9,246,960

Total Administrative Cost

$9,634,144

FINANCIAL SUMMARY FOR THE YEAR ENDED DECEMBER 31, 2014 (UNAUDITED DOLLARS)

Total Revenue $92,370,613

Total Expense $92,730,066

36

2015 ANNUAL REPORT

DONORS

57 Bay Street Associates

Lorraine S. Aaron u

Aaronson Rappaport Feinstein & Deutsch, LLP u

Mr. Arthur A. Abeles

Abilene, Inc.

Mr. Herbert Aboff

Mr. and Mrs. Michael Aboff u

Aboffs Inc.

Mr. and Mrs. Richard S. Abramson l

Louis & Anne Abrons Foundation Inc.

Mr. and Mrs. William Achenbaum l

Mr. and Mrs. Richard H. Ader

Mr. Paul R. Ades u

The Adikes Family Foundation u

Advantage Title Agency, Inc.

AdvantageCare Physicians

Aeroterm US Inc. AAF

AFCO Insurance Premium Finance

Affinion Group

Aflac

Ms. Galina Agapov

Mr. Herbert S. Agin and Dr. Denny Agin

Mr. Greg A. Agran u

Ainslie Foundation

Air Serv Corporation

Airline Vending Services, Inc.

Airway Maintenance, LLC

The Alan T. Brown Foundation to Cure Paralysis

Mona Fishman Albert and Andrew Albert s

Mr. and Mrs. Wayne Albinder

Alcon Laboratories, Inc.

Mr. and Mrs. Michael W. Alderman

Mr. and Mrs. Michael J. Alesandro u

Mr. and Mrs. John W. Alexander u

Allergan, Inc.

AllianceBernstein

Alliance for Lupus Research s

Alliance Ground International, LLC

Allied Aviation Services, Inc

Alonna, LLC

Ms. Adelah AlSayer

Mr. and Mrs. Charles M. Alter

Mr. and Mrs. Philip S. Altheim u

Altman Warwick, Inc.

American Academy of Dermatology

American Academy of Family Physicians Foundation

American Heart Association u

American Land Services, Inc.

American Orthopaedic Society for Sports Medicine

American Regent, Inc.

American Signcrafters

The American Society of Hematology u

Mr. and Mrs. Peter Amoruso

Amster, Rothstein & Ebenstein LLP

Mr. and Mrs. Albert Anastasi

Mr. and Mrs. Arthur A. Anderman s

Ms. Christine Anderson-Vietri

Angels on the Bay, Inc. u

The Anikstein Family u

Annidis Health Systems Corporation

Anonymous l

Anonymous s

Anonymous u

Anonymous

Mr. Charles Apelian

Mr. and Mrs. Nishan Apelian l

Apollo Security, Inc.

Appliance World of Huntington

Dr. Brahim Ardolic

Arizona Beverages USA

Arnone, Lowth, Wilson, Leibowitz, Andriano & Greco, Inc.

Mr. and Mrs. Carlos A. Arredondo

Ms. Elena I. Arredondo

Ms. Marisa Arredondo

Mr. William Artemenko

Arthritis Foundation

Mr. and Mrs. Russell M. Artzt s

ASCAP u

Mr. and Mrs. George Asch u

Ms. Margaret M. Ash

Mr. and Mrs. Michael L. Ashner l

Assets Recovery Center, LLC

Dr. and Mrs. Mark E. Astiz

Astoria Bank s

Atria Senior Living u

Au Bon Pain

AXA Advisors

Mr. and Mrs. Stuart F. Ayre

Mr. and Mrs. Henry D. Babcock, Jr.

BAE Systems

N. Bailey & H. Kirshner Foundation

Mr. and Mrs. Morgan Bale

Ms. Audrey R. Balog

Mr. and Mrs. Thomas M. Bancroft u

Norwood Foundation, Inc.

Mr. and Mrs. Douglas Band

Banfi Vintners Foundation s

Bank of America, N.A. s

Jeanine and Merrill Banks u

Lloyd Staffing

BankUnited

Ms. Joanne Barbara u

2014 Honor RollThe North Shore-LIJ Health System is grateful for the continued support of so many friends. We wish to thank all of our donors whose generosity and ongoing partnership enable us to fulfill our mission of improving the health of the communities we serve.We make every effort to be accurate and complete in this donor listing. If you have any questions with regard to how your name and/or organization appears, please contact the North Shore-LIJ Health System Foundation at 516-465-2550.The names listed below represent donors, corporations and foundations that have made cumulative gifts of $2,500 or more in 2014. Symbols appearing next to listings reflect lifetime giving.

H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000

37


Barbash Family Fund, Inc. l

Ms. Cathy Barbash l

Mrs. Lillian Barbash l

Mr. Shep Barbash l

Ms. Susan Barbash l

Harbour Club, LLC

Mr. and Mrs. Christopher J. Barber u

Mr. and Mrs. Anthony F. Barbiero

Barclays Capital

Judy and Ron Baron

Mr. and Mrs. Manuel H. Barron

Mr. and Mrs. Stanley F. Barshay u

Bartlett, McDonough, Bastone & Monaghan, LLP u

Mr. and Mrs. Ralph M. Baruch l

Mrs. Sandra Atlas Bass H

Mr. David W. Baum u

The Incorporated Village of Bayville

Mr. Kevin S. Beiner

Dr. Alessandro G. Bellucci

Mr. and Mrs. Paul Berger

The Sol and Margaret Berger Foundation l

Mr. James Bergstrom

The Berlin Family Foundation u

Mr. and Mrs. Sidney Berman

Mr. Martin W. Bernard u

Mr. Abraham Bernstein

Jill and Jay Bernstein Family Foundation u

Mr. and Mrs. Frank J. Besignano

Bessemer Trust

Bestcare, Inc.

Bethpage Federal Credit Union

David J. Beyda Memorial Foundation

Ms. Jennifer L. Bickhardt

Biener Auto Group Inc.

Carl Vincent Bini Memorial Fund

Biomedical Research Models, Inc.

Bio-Reference Laboratories u

Mr. and Mrs. O. F. Biondi Jr.

Biotronik, Inc

Dr. Fabien D. Bitan

Mr. and Mrs. Leon Black u

Ms. Elise M. Bloom and Mr. Gregory I. Rasin

Bloomingdales u

Mr. Eric S. Blumencranz s

BWD Group, LLC

Mr. and Mrs. Roger A. Blumencranz l

BWD Group, LLC

Mr. and Mrs. Edward Blumenfeld and Family l

Mr. Charles Blumenkehl

Mr. and Mrs. J. Robert Blumenthal

BNP Associates, Inc

Mr. and Mrs. Andrew Boas l

Dr. and Mrs. Richard S. Boas l

Mr. and Mrs. John Bohlsen n

Bohlsen Restaurant Group

Mr. and Mrs. Geoffrey T. Boisi s

Dr. and Mrs. Richard J. Bonanno

Mr. and Mrs. Joseph Bongiorno

ADJO Contracting Corporation

Mr. and Mrs. Anthony Bonomo l

Physicians Reciprocal Insurers

Dr. John A. Boockvar

Boston Scientific Corporation u

Botto Mechanical Corporation

Mr. William Bowles

Mr. Kevin Boyle

BP Elevator Co.

Brain and Behavior Research Foundation l

The Brain Aneurysm Foundation u

Dr. Lenore Brancato and Dr. Louis Potters

Norbert & Henry Bratt Charitable Trust

Mr. E. Steve Braun H

Mr. and Mrs. Harry P. Braunstein

Dr. Richard Braunstein

Brean Capital, LLC

Mr. Fred Brettschneider

Laura Louise Breyer

Bridgehampton National Bank

Bridgehampton Stone, Inc.

Bridgewater Associates, LP

Dr. Derek Brinster

Brock Solutions

Mr. and Mrs. Bert E. Brodsky u

Mr. and Mrs. Chester F. Broman

Mr. and Mrs. Robert Brooks

Mr. and Mrs. Dayton T. Brown, Jr. l

The William Brown Foundation, Inc. u

Mr. Daniel H. Broxmeyer

Mr. Evan Broxmeyer

Estate of Mark Broxmeyer l

Mr. and Mrs. Michael Broxmeyer

Ms. Rebecca Broxmeyer

Mrs. Tracy L. Broxmeyer l

Dr. Michael S. Bruno l

Estate of Emelda E. Burns u

Busch White Norton, LLP

Mr. and Mrs. Allen E. Busching u

Drs. Annabella Bushra and Peter Abrons

Dr. Richard T. Byrnes

CA Technologies H

Cablevision

Mr. Joseph R. Cabral

Dr. Jean Cacciabaudo and Dr. William Maiorino

Mr. Joseph G. Cairo, Jr.

The Pat Cairo Family Foundation Inc. u

Mr. and Mrs. Salvatore Calcagno

Mr. James W. Callanan

Cameo Import Inc.

Cameron Engineering & Associates, LLP

Mr. and Mrs. William J. Candee, III

Ann and Peter Cannell u

Jonathan S. Canno and Pierce Roberts Canno s

Capell, Barnett, Matalon & Schoenfeld, LLP

Mr. Salvatore Capitano

Ms. Lucinda M. Cardinal and Mr. Daniel S. Tamkin u

Mr. and Mrs. Michael G. Caridi u

Carillon Nursing & Rehabilitation Center

Mr. and Mrs. Robert A. Carlstrom u

Dr. Maria T. Carney and Mr. Joseph M. Carney

Bonnie Cashin Fund

Dr. Miriam Caslow and Mr. Robert J. Caslow

Mr. and Mrs. Frank Castagna l

Fifth Avenue of L.I. Realty Associates

Mr. and Mrs. Robert F. Castano

Mr. Peter Castle

Mr. Frederick Catanese

Mr. and Mrs. Robert B. Catell s

Ms. Colleen Cavaliere

Centennial Elevator Industries, Inc.

Central General Medical & Dental Staff u

Century 21 Associates Foundation Inc. u

Century Elevator Maintenance Corporation

The Anthony Cerami and Ann Dunne Foundation for World Health l

Certilman Balin Adler & Hyman, LLP u

Clifford Chance US, LLP

Dr. Kenneth B. Chapman

Charles H. Thorne, M.D., PLLC

The Chasanoff Foundation, Inc. l

Mr. and Mrs. Robert W. Chasanoff l

Mr. Stanley Chera

Mr. and Mrs. Edward A. Chernoff l

MARS

Childrens Hospital Foundation

Childrens Medical Fund of New York H

Childrens Miracle Network Hospitals n

Mr. Richard Chipman u

CHIPS Technology Group, LLC

Mr. Andrew Chonoles

Chubb & Son, Inc.

Cigna Health and Life Insurance Company

Cincinnati Childrens Hospital Medical Center

Circulatory Technology, Inc. u

Citigroup

Mr. and Mrs. Jerry Clair u

Ms. Joan Claster and Mr. Leonard Kaye

Mr. and Mrs. Mark L. Claster n

Carl Marks Foundation, Inc.

The Clinton Family Foundation

CLK Commercial Management

CLL Global Research Foundation u

Club House Italia of USA LLC

CNA Foundation

Estate of Arthur G. Cohen

Mr. and Mrs. Edward M. Cohen

Hiram Cohen & Son, Inc.

Mr. and Mrs. Jonathan Cohen

Mr. and Mrs. Michael S. Cohen

Mr. and Mrs. Ronald Cohen

Ms. Sharon J. Cohen l

Mr. and Mrs. Steven A. Cohen H

Mr. and Mrs. Steven M. Cohen and Mrs. Bernice Cohen l

38

2015 ANNUAL REPORT

Mr. and Mrs. Maurice J. Cohn l

Max B. Cohn Family Foundation

Mr. Seymour Cohn

Sol Cohn Foundation

Estate of Louise Colavito

Cold Spring Hills Center for Nursing & Rehabilitation

Ms. Karen Coleman

Mr. and Mrs. John K. Colgate, Jr. s

Simon & Eve Colin Foundation, Inc. u

Colliers International LI Inc.

Compass Group, North America

Computershare Trust Company of Canada

Mr. Michael Condran

Mr. Dennis Connors

Mr. Thomas Constance

Mr. Michael P. Contillo

Mr. and Mrs. Robert F. Castano

Mrs. Alison Conyngham Neisloss

Conyngham Foundation Agency

Frederic W. Cook & Co., Inc.

Mr. Jonathan D. Cooper

Spectronics Corporation

Mr. and Mrs. John Corrado

The Corso Family Foundation - Care of Joseph Corso

Mr. and Mrs. Konstantine Costalas

Dr. and Mrs. Peter D. Costantino

Costco Wholesale l

Ms. Eileen V. Costello

The Craigmyle Foundation s

Cravath, Swaine & Moore LLP

Dr. and Mrs. James M. Crawford

Credit Union Miracle Day, Inc.

Mr. and Mrs. Peter O. Crisp n

Mr. and Mrs. Brad Cronin

Ellen and Daniel Crown l

Dr. Eric S. Cruzen

Ms. Josephine Cupo

Michele and James Cusack

Drs. Patricia and Fred Cushner

Cystic Fibrosis Foundation u

D & D Elevator Maintenance, Inc.

Drs. Catherine A. DAgostino-Barakat and Richard R. Barakat

Dr. John DAngelo

Mr. and Mrs. Joseph F. DAngelo u

DAL Global Services, LLC

Jillian E. Daly Foundation u

Damaghi Families l

Farahnaz and Babak Damaghi

Haleh and Kambiz Damaghi

Mitra and Nader Damaghi

Shahnaz and Nasser Damaghi

Morris & Rose Danzig Charitable Trust u

Mr. and Mrs. Philippe P. Dauman u

David Lerner Associates u

Mr. Robert G. Davidoff

Estate of Irwin Davis l

Ms. Katherine M. Davis

Mr. and Mrs. Lawrence S. Davis l

Davis Vision

Ms. Alyssa Davner

Mr. and Mrs. Francois X. de Mallmann

The De Rosa Foundation for Colon Cancer Research and Prevention u

Mrs. Vincent de Roulet l

Ira W. DeCamp Foundation u

DeCorato Cohen Sheehan & Federico u

Degmor, Inc.

DEI Incorporated

Peter & Jeri Dejana Family Foundation u

Mr. and Mrs. Claudio Del Vecchio

Deloitte & Touche LLP

Delta Air Lines u

Dr. and Mrs. Louis DeLuca

Mr. and Mrs. Manfred E. Demenus

Dentons

Department of Pediatrics, SIUH

Mr. and Mrs. Thomas E. Dewey, Jr. s

Dr. Kush Dholakia

Diamond Blackfan Anemia Foundation

The DiBenedetto Family Foundation

DiFazio Power & Electric, LLC

Mr. and Mrs. Jack DiMaio

Mr. Joseph DiMartino u

Dime Savings Bank of Williamsburgh

Dr. Michael Y. Divon u

Donaldson Interiors, Inc.

Mr. and Mrs. Thomas E. Dooley l

Mr. and Mrs. Lawrence Doppelt u

Barbara Dorsch Foundation

Mr. and Mrs. John C. Doscas

Douglas Elliman Real Estate u

Mr. and Mrs. Michael J. Dowling

Robert N. and Nancy A. Downey l

Mr. Damien Drab

Mr. and Mrs. Daniel J. Driscoll

Mr. and Mrs. Michael J. Driscoll

Mrs. Ruth A. Drucker u

Duenas Trucking

Duffner & Voigt Inc.

The Norma Duncan Testamentary Trust

Dunkin Donuts/Baskin Robbins Foundation

Mr. Thomas Durkin

E.I.B. LMCC Fund

Eagle Capital Management, LLC

Henry M. Ebbitt Trust

Paul R. Eckna Memorial Foundation

Dr. David R. Edelstein and Ms. Eve Lesser

Edgewood Management, LLC

The Eger Foundation

Mr. and Mrs. David Einbinder u

Dr. and Mrs. Mark B. Eisenberg

Mr. and Mrs. Martin Eisenberg

Mr. and Mrs. Ronald Eisenberg

Mr. and Mrs. Saul Eisenberg u

The Charles L. Read Foundation

Mr. and Mrs. Warren Eisenberg u

Eisenhardt Mills, Inc.

Mr. and Mrs. Adam Elberg

Mr. Christopher Eler

Mr. Martin Elias l

Ike, Molly & Steven Elias Foundation

Ms. Theresa Elkowitz

Dr. Marty Ellington

Thomas and Jeanne Elmezzi Private Foundation H

Emergency Medicine Services of SI, PC u

Empire Office Equipment

Endometriosis Foundation of America, Inc. u

Mr. and Mrs. Peter Engel

Mr. and Mrs. Daniel Englander u

Mr. and Mrs. Israel Englander l

Mr. Charles Entenmann u

Mr. Robert Entenmann

Family of William Entenmann

Entertainment Industry Foundation

Epilepsy Foundation

Epilepsy Study Consortium, Inc.

Mr. Michael Epstein and Ms. Lisa Martin Epstein l

Dr. and Mrs. Neal F. Epstein

Mrs. Phyllis Epstein

Mr. and Mrs. Scott Erlich

Essig Electrical Services, Inc.

The Estee Lauder Companies Inc. s

Etchepare Family Foundation

Mr. and Mrs. Bernard Ettinger u

Evercore Trust Company

Extended Nursing Personnel, CHHA u

ExxonMobil Foundation

Eye Care Centers of America, Inc.

EZE Software Group

F.A.C.T. Long Island Foundation

Fache Industries, Inc.

Faegre Baker Daniels, LLP

Mr. and Mrs. Peter M. Fahey u

Fan Fox and Leslie R. Samuels Foundation, Inc. l

Farrell Fritz, P.C.

Ms. Cara Faske

FBR Capital Markets & Company

Foundation of the American College of Allergy, Asthma & Immunology

Mr. and Mrs. Robert Feidelson

The Louis and Gertrude Feil Family H

Mr. David H. Feinberg

Mr. and Mrs. Frank Feinberg H

Mr. and Mrs. Herbert Feinberg u

Drs. Sheryl and Randall Feingold

Ms. Amy Feinstein u

Mr. and Mrs. Jeffrey L. Feinstein u

Mr. and Mrs. Leonard Feinstein H

Mr. and Mrs. Richard S. Feinstein u

Mr. and Mrs. Michael E. Feldman u

Ms. Ann Feldstein

Mr. and Mrs. Marshall Felenstein u

Mrs. Amy Feller

Mr. and Mrs. Larry Fenster

Mr. and Mrs. Anthony C. Ferreri u

Mr. and Mrs. Christopher C. Ferreri

Mr. and Mrs. Joseph Ferreri

Mr. and Mrs. Fredric Fetkowitz

Ficalora Family Foundation u

H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000

39


Dr. and Mrs. David H. Fields u

Dr. and Mrs. Noah S. Finkel

Mr. and Mrs. David S. Finkelstein

Joel Finkelstein Cancer Foundation H

Mr. and Mrs. Brian Finn u

First Presbyterian Church The Clothes Line

Fiserv Solutions, Inc.

Mr. and Mrs. Daniel Fisher u

Mr. and Mrs. Robert Fisher

Dr. Nick Fitterman

Five Corners Car Wash

Flightstar Aircraft Services, LLC

Florence Corporation

Mr. and Mrs. Thomas J. Flynn u

The Ford Foundation

The Morris and Natalie Forgash Foundation

Mr. Alan Forman

Altronix Corporation

Dr. Victor Fornari

Dr. Jamie A. Fortunoff and Dr. Paul P. Romanello

Mr. and Mrs. Robert Fortunoff u

The Foundation for READ

Foundation for Surgical Fellowships u

The Foundation of the AAGL

Michael J. Fox Foundation for Parkinsons Research s

FragranceNet.com

Frank Crystal & Company

The Frank Family Foundation

Abraham B. & Sarah Frank Fund u

Dr. and Mrs. Douglas K. Frank

Franklin Hospital - Medical Staff Fund s

Mr. and Mrs. William H. Frazier u

Fresh Meadow Country Club s

Mrs. Carolyn W. Fried

Dr. Ethan Fried and Mrs. Joan Bester

The Fried Foundation, Inc. u

Fried, Frank, Harris, Shriver & Jacobson, LLP

The Raphael D. and Francine Friedlander Foundation l

Friedman Benda, LLC

Mr. Clifford H. Friedman u

The Gerald J. and Dorothy R. Friedman New York Foundation n

Ms. Ruth Friedman

Friends and Angels: The Tracy Vicere Foundation, Inc.

Friends of Maya Chang, Inc.

Mr. Scott Frishman u

Philip J. Hahn Foundation

Mr. Glen Froio

Mr. and Mrs. Tony Fromer

Mr. and Mrs. Robert L. Fromer l

Mr. Alan J. Fumuso

Fumuso, Kelly, DeVerna, Snyder, Swart & Farrell, LLP

Estate of Agnes Trill Funk u

The G & A Foundation u

Mr. and Mrs. Henry Gabbay u

Mr. and Mrs. Gregory G. Galdi

Custom Computer Specialists

Mr. Stanley C. Gale s

The Gambino Medical & Science Foundation, Inc. n

Mr. and Mrs. Thomas Gambino, Sr.

Mr. and Mrs. Leif Arntzen

Mr. and Mrs. Carl Gambino

Mr. and Mrs. Thomas Gambino, Jr.

Mr. and Mrs. Andrew Rotondi

Howard L. and Judie Ganek Philanthropic Fund

Garden City Rams - Boys Lacrosse, Inc.

Estate of Robert B. Gardner, Jr. l

Garfunkel Wild, P.C. u

Dr. Kirk N. Garratt

George A. Gaston Charitable Trust u

Gates Capital Corporation

Mr. Eric Gatoff

Nathans Famous Services, Inc.

Gavins Got Heart

Mr. Michael J. Geiger

Genentech, Inc. u

Mr. and Mrs. Robert Genser

Ms. Gladys George and Dr. Stuart Orsher s

Mr. and Mrs. Raymond L. George, III

Mr. and Mrs. Gary M. Geresi

Myrna and Freddie Gershon

The Gershwind Family Foundation l

Mr. and Mrs. J. R. Getz

Mrs. Ronnie Pashcow Getz

GGG Construction Corporation

Ms. Rene A. Giacalone u

Mr. and Mrs. Anthony T. Giaccone u

Intermarket Insurance Agency Inc.

Mr. and Mrs. Christopher C. Giamo

Mr. John V. Gibson u

Mr. and Mrs. Alan R. Gilbert

Mr. S. Parker Gilbert u

Gilead Sciences, Inc.

Mr. and Mrs. Edward M. Giles

The Clark Gillies Foundation l

Aaron & Betty Gilman Family Foundation

Mr. Abraham Gindi u

Mr. and Mrs. Myron Ginsberg

Giorgio Armani Emporio Armani

Glen Head Charity Fund, Inc. u

Glen Oaks Club, Inc. u

Glen Oaks Philanthropic Fund u

Mr. and Mrs. Ralph Glogower

Roy Henry Glover Memorial Trust s

Mrs. Pearl Glowatz

GM Advisory Group

Mr. and Mrs. Robert Goebert

The Arnold P. Gold Foundation

Mr. Marc Gold

Mr. and Mrs. Alan Goldberg u

Mr. and Mrs. Arthur H. Goldberg u

Edward & Marjorie Goldberger Foundation

Mr. and Mrs. Richard Goldberg

Mr. Robert M. Goldberg n

The Fay J. Lindner Foundation

Dr. and Mrs. Bruce Golden

Mrs. Mildred Golden u

Ms. Edna S. Goldman u

Mr. Jay Goldman l

Mr. and Mrs. Lloyd M. Goldman H

The Joyce and Irving Goldman Family Foundation

Goldman Sachs & Co. l

Elliot Goldofsky, M.D., P.C.

Mrs. Lola Goldring

Mr. and Mrs. Richard D. Goldstein l

Sarah C. Goldstein Irrevocable Trust u

Mr. and Mrs. Robert L. Golub

Mr. and Mrs. Ernest P. Gonzalez

Goodhart National Gorman Agency, Inc.

Dr. and Mrs. Merrill Goodman s

Goody Two Shoes & The Schnittman Family

Mr. and Mrs. Donald J. Gordon u

Gordon & Silber, P.C.

Gordon L. Seaman, Inc. u

Mr. Lawrence Gottesman s

Lawrence Scott Events, Ltd.

Mr. and Mrs. Ronald A. Gottlieb u

Mr. and Mrs. George E. Gottridge s

Dr. Joanne Gottridge-Patrizi and Mr. Lester Patrizi u

Mr. and Mrs. Fredric H. Gould s

The Gould-Shenfeld Family Foundation

Mr. Michael A. Gould s

The Sarah Grace Foundation for Children with Cancer, Inc.

Grandstand Sports & Memorabilia, Inc.

Dr. and Mrs. Albert L. Granger

Granger & Sahasra Endodontic

Granite Building 2 LLC

Mr. Martin Granowitz

Dr. and Mrs. Jeffrey J. Grant u

Great South Bay Y.M.C.A.

Green Art Plumbing Supply

Mr. and Mrs. Martin B. Greenberg s

Mr. and Mrs. Alan I. Greene H

The David and Alan Greene Family Foundation, Inc.

Mr. and Mrs. Richard M. Greene u

The Niki and Joe Gregory Charitable Foundation l

Gristmill Construction Company, LLC

Mr. and Mrs. Leonard S. Gruenberg, Jr.

The Vincent Gruppuso Foundation u

Ms. Joanne Grzelak

Mr. and Mrs. Paul A. Guden

Mr. and Mrs. Lee E. Gunderson

Mr. Francis C. Gunther

Mr. and Mrs. Joseph Gurwin l

Dr. Leo Guthart u

Patricia and Edward Gutman l

The Gynecologic Oncology Group

The H Company, Ltd.

Dr. Robert D. Haar

The Marc Haas Foundation u

Mr. and Mrs. Adam Haber

Ms. Trudi Haberman

40

2015 ANNUAL REPORT

Amy Hagedorn n

Mr. and Mrs. Peter R. Haje

Mr. and Mrs. Stephen L. Hammerman s

Hampton Designer Showhouse Foundation, Inc.

Milton and Miriam Handler Foundation s

Hanley Funeral Home, Inc.

Mr. and Mrs. Bernard Hann l

Jeri Finesilver Cancer Foundation

Harboglow, Inc.

Mr. and Mrs. Robert L. Harding s

Harding Educational and Charitable Foundation

Harmonic, Inc.

Ms. Erica Harold

Mrs. Tara Hart and Mr. Edward Tam

Dr. and Mrs. Alan R. Hartman

Mr. and Mrs. Norman H. Harvey u

Mr. Walter H. Haydock

Mr. and Mrs. Stuart M. Hayim u

Mr. and Mrs. Ira Hazan l

Healthcare Association of NYS & Affiliates

Healthfirst, Inc.

Mr. and Mrs. Michael F. Heaney

Friedman, LLP

The William Randolph Hearst Foundations, Inc. l

The Hecht-Levi Foundation

Dr. and Mrs. Lawrence P. Hecker

Heidelberg Engineering

Heidell, Pittoni, Murphy & Bach, LLP

Mr. and Mrs. Steven D. Heinemann

Benjamin J. Heitner, C.P.A., P.C.

Ms. Mary Jane Helenek

Mr. and Mrs. Jonathan N. Helfat u

Mr. Alexander Hellinger

Dr. Jonathan Hemli

Mr. Matthew Henebry

Henry Schein, Inc. s

Elliott and Susan Hershman u

Mr. and Mrs. John B. Hess u

Marlene Hess and James D. Zirin H

Mr. Stephen Hess u

Hewlett Associates, LP

Hightower Holding, LLC

William and Judy Hiltz l

Mr. and Mrs. Randall S. Hinden u

Margaret Mellon Hitchcock Foundation u

Dr. and Mrs. Mark S. Hochberg

Dr. Gary Horbar and Dr. Sharon Hochweiss

Dr. Cynthia and Mr. Robert Hoey

Drs. Ira and Ruth Hoffman u

Mr. and Mrs. Peter J. Hoffman

Mr. and Mrs. Steven R. Hoffman

Helen Hoffritz Charitable Trust s

Hofstra University

Mr. and Mrs. Ronald P. Hohmann

Dr. Peter H. Hollis

Holten Ave., Inc.

The Honeysuckle Foundation for Children with Cancer u

Mr. and Mrs. James B. Hoover u

Dr. Gary Horbar and Dr. Sharon Hochweiss

Mr. and Mrs. Richard A. Horowitz u

Mr. and Mrs. Ron J. Horowitz s

P & F Industries, Inc.

Ms. Catherine Hottendorf

Mr. and Mrs. Randolph G. Howard, Jr.

Mr. and Mrs. David J. Hoyt

HRI Health Research Inc. u

HSBC Philanthropic Programs

Mr. and Mrs. Charles G. Hughes

C. G. Hughes Company

H. M. Hughes Co., Inc.

Hugoton Foundation l

Hunter Douglas

Hunter Roberts Construction Group

Huntington Country Club

Huntington Hills Center for Health & Rehabilitation

Huntington Hospital - Medical Staff s

Huntingtons Disease Society of America u

Mr. and Mrs. Laurence S. Hyman

Mr. and Mrs. M. Allan Hyman u

Ms. Nicole Iacovano

I Chera & Sons Foundation, Inc.

ICOR Associates, LLC

I.J. Peisers Sons, Inc.

Illumina, Inc.

Mr. and Mrs. Richard C. Imbert l

Impact Displays Group

InfoHedge Technologies

Mr. and Mrs. Francis Ingrassia u

Intelli-Tec Security Services

Interboro Management, Inc.

International Asbestos Removal Inc.

International Trade Logistics, Inc.

Investors Bank Foundation

Iranian American Jewish Federation of New York u

Dr. Tochi Iroku-Malize

ISK Institute for Orthopedics and Sports Medicine

Island Medical Specialists, PLLC

Islip Breast Cancer Coalition

ISS Facility Services, Inc.

Mr. Chander S. Iyer u

Mr. Anthony T. Izzo u

Benefits Planning Corporation

Mr. Mark Jacobson l

Mr. and Mrs. Mitchell Jacobson l

MSC Industrial Direct Company, Inc.

Mr. and Mrs. Scott Jaffee

Dr. and Mrs. Mark P. Jarrett

Jaspan Schlesinger, LLP

Estate of Elmer L. Jefferson l

Estate of Helen T. Jefferson u

Mr. and Mrs. James P. Jeffery

JemCap LLC

Jet Way Security & Investigations, LLC

Jewish Community Foundation of Greater Hartford, Inc.

JFK International Air Terminal, LLC

The John W. Engeman Theater at Northport

Jonathan Quattrocchi Sheetrock & Spackling

Mr. and Mrs. Michael D. Jordan u

Mr. Arlin Jorge u

Arlindo & Evelyn Jorge Family Trust u

JPMorgan Chase l

J.S. Held Incorporated

Arnold and Ann Jurdem

Mr. and Mrs. Jeffrey Jurick s

Mrs. Lyn Jurick l

Mr. and Mrs. Harvey B. Kadden

Estate of Marion A. Kahn l

Mr. and Mrs. Edward Kalikow

The Sidney & Pearl Kalikow Foundation

Mr. and Mrs. Jeffrey M. Kanter

Mr. and Mrs. Allen S. Kaplan

Mr. and Mrs. Ramesh Kapoor u

The Karches Foundation H

Mr. and Mrs. Brad Karp

Sotirios Kassapidis, MD, P.C.

Katten Muchin Rosenman Foundation, Inc.

Mr. and Mrs. Alvin Katz

Mr. and Ms. David M. Katz

Ms. Holly Katz

Mr. and Mrs. Michael Katz l

Mr. and Mrs. Robert Katz u

Mr. and Mrs. Saul B. Katz H

Mr. and Mrs. George S. Kaufman

Mr. and Mrs. Ivan Kaufman l

Mr. and Mrs. Marvin A. Kaufman u

Mr. and Mrs. Robert Kaufman n

Mr. and Mrs. Steven Kaufman

Kaufman, Borgeest & Ryan, LLP

Mr. George Kaye

The Kazickas Family Foundation, Inc.

Kck, Inc.

Mr. and Mrs. John C. Kean, III u

Kean Development Company

W.M. Keck Foundation u

The Kelleher Foundation

Kellenberg Memorial High School

Kelley Drye & Warren, LLP u

Mr. and Mrs. Jack Kelly

Mr. Michael Kelly

Mr. and Mrs. Marc Kemp

Mr. and Mrs. J. Donald Kennedy u

Kenneth J. Delaney Contracting Corp.

Dr. James F. Kenny u

Mr. Paul Kesluk

Kidney & Hypertension Specialists of New York, P.C.

Dr. Michael Kim

The David Kimmel Foundation u

Mr. John J. King u

King Kullen Grocery Co., Inc. u

Dr. and Mrs. Alan M. Kisner

Mr. and Mrs. William Kissam

Kiwanis Club of Huntington Childrens Foundation Inc.

Kiwanis, Metropolitan Division

Kiwanis Pediatric Trauma Center, NSUH l

H $10,000,000+ n $5,000,000 l $1,000,000 s $500,000 u $100,000

41


The Nancy Klauber Forest Foundation u

Dr. Arthur A. Klein

Dr. Victor R. Klein

Dr. Morton Kleiner u

Mr. Mark T. Kleinknecht and Ms. Jessica A. Harter-Kleinknecht

Mr. and Mrs. Richard P. Kleinknecht u

The Kleinknecht Family Foundation

Mrs. Marion Kleinkramer u

KLS Martin, L.P.

B & R Knapp Foundation, Inc. u

Ms. Susan Knoepffler

Mr. and Mrs. David M. Knott u

Kohls Cares l

Ms. Stephanie Kollar

Susan G. Komen Greater New York City u

Dr. Arnold Komisar

Kone, Inc.

Mr. and Mrs. Peter Kossoy

Karen M. Kostroff, MD and Jon R. Cohen, MD u

Mr. and Mrs. Jeffrey T. Kovner u

The Judith C. White Foundation, Inc.

KPMG, LLP u

Mr. and Mrs. Werner H. Kramarsky

Kramer Levin Naftalis & Frankel, LLP

Mr. and Mrs. Jeffrey A. Kraut

Mr. and Mrs. Cary A. Kravet l

Kravet, Inc.

Mr. and Mrs. Scott Kravet

Mr. Stanley Kreitman l

Dr. Yosef P. Krespi

Estate of Florence B. Kressin l

Ms. Francine Kreuter

Mrs. Cathy S. Krieger

Mr. Stuart Kronick

Mrs. Barbara W. Kummel u

The Kupferberg Foundation l

Mr. Max Kupferberg l

Mr. and Mrs. Seth Kupferberg l

Jack & Dorothy Kupferberg Family Foundation

Dr. Marina S. Kurian

Dr. Daniel B. Kuriloff

Dr. Michael Kurzman

The Kurzrok Foundation, Inc.

Mr. and Mrs. Sheldon F. Kwiat u

Dr. and Mrs. Sean Lager

Lakeville Pace Mechanical, Inc.

Mr. and Mrs. Frank Lalezarian u

Mr. and Mrs. Kevin Lalezarian u

Mr. and Mrs. Brian T. Lally

LaMay & Sons, Inc.

Mr. and Mrs. Ralph E. Lambert u

Axis Construction Corporation

Landauer, Inc.

Mr. and Mrs. Jerry Landsberg u

Mr. and Mrs. Clifford P. Lane l

Mr. Hank Lane

Mr. and Mrs. Jeffrey B. Lane l

Mr. Robert Lane

Dr. David Langer

Mr. and Mrs. Alexander M. Laughlin u

Mr. and Mrs. Curtis N. Launer s

The Bernard and Muriel Lauren Foundation

Mr. and Mrs. Mark Lauria u

Mark Lauria Associates, Inc.

Mr. and Mrs. Benjamin Lavon

The Alice Lawrence Foundation, Inc.

Dr. and Mrs. Richard S. Lazzaro

Sol and Mildred Lederman Supporting Foundation u

Dr. and Mrs. David LeDoux

Mr. and Mrs. Gerard G. Leeds l

Mr. and Mrs. Michael S. Leeds l

Mrs. Susan C. Lehrman s

Mrs. Isabel B. Leib

Mr. and Mrs. Jonathan W. Leigh l

Dr. and Mrs. Lyle S. Leipziger u

Lenox Hill Hospital OB/GYN Department

Lenox Hill Medical Anesthesiology, PLLC s

Mr. and Mrs. Leslie A. Lerner

Mr. and Mrs. John Lesser

Mr. and Mrs. Howard M. Lester

The Leukemia & Lymphoma Society, Inc.

Mr. and Mrs. Arthur S. Levine l

Mr. Laurence A. Levine

Dr. Mitchell E. Levine

Mrs. Marjorie Boas Levins and Mr. Jack Levins n

Mrs. Shirley I. Leviton l

Mr. and Mrs. Mark Levitt

Estate of Leo J. Levy u

Mr. and Mrs. Mark D. Levy

Mrs. Valerie Levy u

Mr. and Mrs. Victor P. Levy s

L.I. Automotive Group

Mr. George J. Liebner

Lifetime Brands, Inc.

Mr. and Mrs. Martin Lifton l

Lightpath, Inc.

Mr. and Mrs. Mark S. Lilling u

Limo Almi Foundation l

Mr. and Mrs. Peter J. Linchitz

Mr. and Mrs. Andrew S. Linde

Documents

View the latest Feinstein Institute for Medical Research annual report